Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6800
+0.0200 (1.20%)
NASDAQ· Last Trade: Jun 11th, 2:36 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors